10x Genomics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-10.7M | $-14.5M | $3.8M | $1.7M |
| FY2018 | $-76.4M | $-82.7M | $6.3M | $2.7M |
| FY2019 | $34.6M | $-8.1M | $42.7M | $13.3M |
| FY2020 | $-217.9M | $-254.6M | $36.7M | $48.6M |
| FY2021 | $-21.4M | $-122.7M | $101.3M | $96.0M |
| FY2022 | $-33.6M | $-165.3M | $131.7M | $136.8M |
| FY2023 | $-15.2M | $-63.8M | $48.6M | $167.0M |
| FY2024 | $6.7M | $-5.7M | $12.4M | $140.7M |
| FY2025 | $136.1M | $130.1M | $5.9M | $109.1M |